Tatsuro Yamaguchi

24PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples epidemiologyOncology and carcinogenesis not elsewhere classifiedGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 27, 2026
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.

|Dec 17, 2025
Germline Pathogenic Variant Prediction Model for Tumor-Only Sequencing Based on Japanese Clinicogenomic Database.

Masachika Ikegami, Liuzhe Zhang, Makoto Hirata

|Dec 04, 2025
Prevalence of germline pathogenic variants in cancer predisposition genes in the Japanese population.

Tatsuro Yamaguchi, Kazushige Kawai, Misato Takao

|Nov 25, 2024
Modified FOLFOXIRI plus cetuximab versus bevacizumab in RAS wild-type metastatic colorectal cancer: a randomized phase II DEEPER trial.

Manabu Shiozawa, Yu Sunakawa, Takanori Watanabe

|May 25, 2024
Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan.

Tatsuro Yamaguchi, Masachika Ikegami, Tomoyuki Aruga

|Apr 20, 2024
Clinicopathological characteristics of Lynch-like syndrome.

Sakiko Nakamori, Misato Takao, Akinari Takao

Pageof 4

Frequent Collaborators

2 joint publications

Hideki Ueno

2 joint publications

Yu Sunakawa

2 joint publications

Masachika Ikegami

1 joint publications

Masaaki Ito